SEC Tracker
Get the app

Privia Health Group PRVA

Privia Health Group Q3 FY25: net income $6.9M, up 94%; diluted EPS $0.05

Form
10-Q
Filed
Period
Importance
Notable

Key figures from this report

These are the numbers Privia Health Group reported for Q3 FY25, the quarter ended Sep 30, 2025, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Net income$6.9M+94% from $3.5M in Q3 FY2410-Q income statement, on EDGAR
  2. Diluted EPS$0.05+67% from $0.03 in Q3 FY2410-Q income statement, on EDGAR
  3. Cash and cash equivalents$441.4M+5% from $422.0M in Q3 FY2410-Q balance sheet, on EDGAR
  4. Cash from operations$52.0M+57% from $33.2M in Q3 FY2410-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Privia Health Group files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8000 and related industry codes: the same peer list as the financial tables.

  1. GeneDx Holdings WGS public float $1.7B, Jun 30, 2025
  2. Omada Health OMDA public float $1.1B, Jun 30, 2025
  3. Pennant Group PNTG public float $989M, Jun 30, 2025
  4. LifeStance Health Group LFST public float $817M, Jun 30, 2025
  5. U S Physical Therapy USPH public float $737M, Jun 30, 2025